Biểu đồ giá cổ phiếu MBCOF
MBCOF Dự đoán giá cổ phiếu
Marvel Biosciences Corp.
$0.12
1%
$0
Khi đóng cửa: Jun 23, 16:00:00 GMT-4
$0.12
0%
$0
Phiên sau giờ: Jun 23, 20:00:00 GMT-4
Quay lại
Marvel Biosciences Corp. (MBCOF) Dự đoán giá cổ phiếu
Thống kê chính
Giá đóng cửa trước
$0.1191
Giá mở cửa
$0.1203
Phạm vi ngày
$0.1203 - $0.1203
Phạm vi 52 tuần
$0.0892 - $0.241
Khối lượng
--
Khối lượng trung bình
29.4K
Tỷ suất cổ tức
--
EPS (TTM)
-0.03
Vốn hóa thị trường
$7.5M
MARVEL BIOSCIENCES CORP. là gì?
Marvel Biosciences Corp. is a biotechnology company that utilizes a drug redevelopment approach to drug development. The company is headquartered in Calgary, Alberta. The company went IPO on 2019-02-28. The firm develops new synthetic chemical derivatives of the original approved drug for the new disease indication. The company has developed several new chemical entities, using synthetic chemical derivatives of known, off-patent drugs that inhibit the A2a adenosine receptor with application to neurological diseases (depression and anxiety, Alzheimer's, attention deficit hyperactivity disorder (ADHD)), and the non-neurological conditions of cancer and non-alcoholic steatohepatitis. The firm's lead compound, MB-204, is a fluorinated derivative of Istradefylline. The firm is engaged in developing MB-204 for diseases other than Parkinson's disease, specifically depression, Alzheimer’s Disease and liver fibrosis due to non-alcoholic steatohepatitis (NASH). Its wholly owned subsidiary is Marvel Biotechnology Inc.
